VPIM
SGMT icon

Vanguard Personalized Indexing Management’s Sagimet Biosciences SGMT Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$54.6K Buy
10,454
+376
+4% +$2.1K ﹤0.01% 2040
2025
Q4 		$59.7K Buy
+10,078
New +$72.4K ﹤0.01% 1867

Other funds holding SGMT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Vanguard Personalized Indexing Management's SGMT Position: Q1 2026 in Review

Vanguard Personalized Indexing Management increased its Sagimet Biosciences (SGMT) stake by 3.7% in Q1 2026, buying an estimated $2.1K and bringing the position to 10,454 shares worth $54.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2040.

Vanguard Personalized Indexing Management first reported a position in SGMT in Q4 2025 and has held it in 2 quarters since. The position peaked at $59.7K in Q4 2025. 88 funds tracked by Wall St. Rank hold SGMT as of Q1 2026.

  • Vanguard Personalized Indexing Management held 10,454 shares of Sagimet Biosciences worth $54.6K as of Q1 2026.
  • Vanguard Personalized Indexing Management bought 376 Sagimet Biosciences shares in Q1 2026, an estimated $2.1K.
  • Sagimet Biosciences made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #2040 holding.
  • Vanguard Personalized Indexing Management first reported a position in Sagimet Biosciences in Q4 2025 and has held it in 2 quarters since.
  • Vanguard Personalized Indexing Management's Sagimet Biosciences position peaked at $59.7K in Q4 2025.
  • 88 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.